XPRIZE launches $101M Healthspan prize with Hevolution as a founding sponsor

Hevolution Foundation/Healthspan grants and summit

XPRIZE Healthspan, a seven-year competition (2023-2030) with $101M in total prize funding plus $10M bonus for facioscapulohumeral muscular dystrophy therapies, challenges teams to develop therapeutics that restore muscle, cognitive, and immune function by at least 10 years—targeting 20 years if possible—in people aged 50-80 within a year of treatment.

• $101M total prize pool plus $10M FDHD bonus; seven-year competition (2023-2030) with finalist judging in 2026.
• Teams must restore muscle, cognitive, and immune function by minimum 10 years (target 20) in ages 50-80; treatment duration ≤1 year.
• 20 finalist teams advanced; ten received $1M Milestone 2 awards totaling $10M to accelerate clinical trial development.